文献速递类风湿关节炎

不同(类风湿)关节炎表型对患者生活的影响

The impact of different (rheumatoid) arthritis phenotypes on patients' lives.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于tREACH试验中130例未分化关节炎、176例自身抗体阴性RA和331例自身抗体阳性RA患者,比较诊断时、2年后及随时间变化的患者报告结局。自身抗体阴性RA患者在基线和2年时功能损害和躯体健康更差,疾病负担最高;尽管治疗后多数患者疾病活动度低,所有表型仍存在以躯体为主的生活影响。

要点

  • 自身抗体阴性RA患者在基线和2年时功能损害及躯体健康评分均差于其他表型。
  • 2年后所有表型PRO均改善,但功能相关PRO仍差于一般人群,即使疾病活动度低。
  • 临床应常规评估并处理PRO,因低疾病活动度下仍存在持续疾病负担。

核心结论

  • 自身抗体阴性RA患者在所有表型中疾病负担最高。
  • 尽管治疗后多数患者疾病活动度低,所有临床表型仍对患者生活产生相似的显著影响,且主要为躯体方面。

研究设计与样本

  • 基于tREACH试验,该试验为采用达标治疗策略的分层单盲试验。
  • 纳入未分化关节炎130例、自身抗体阴性RA 176例和自身抗体阳性RA 331例。
  • 基线及2年后PRO比较采用方差分析,随时间比较采用线性混合模型,效应量以各PRO的最小临床重要差异(MCID)加权。

主要发现

  • 自身抗体阴性RA患者较自身抗体阳性RA和未分化关节炎患者有更高的疾病负担。
  • 基线和2年后,自身抗体阴性RA患者较其他表型有更多功能损害和更差的躯体成分总结(PCS),而仅在基线时一般健康和晨僵持续时间评分更差。
  • 基线时除自身抗体阳性RA与未分化关节炎之间的功能能力外,MCID均被超过;2年后仅自身抗体阴性RA较未分化关节炎和自身抗体阳性RA的PCS超过MCID。
  • 2年后所有表型的PRO均改善,但测量功能的PRO仍差于一般人群,即使患者疾病活动度低。

关键数值与推荐

  • 基线时除自身抗体阳性RA与未分化关节炎之间的功能能力外,其他PRO的MCID均被超过。
  • 2年后仅自身抗体阴性RA较未分化关节炎和自身抗体阳性RA的PCS超过MCID。

临床怎么用

  • 因低疾病活动度下仍存在持续疾病负担,日常临床中应评估并处理PRO。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare patient-reported outcome (PRO) domains between three arthritis phenotypes [undifferentiated arthritis (UA), autoantibody-negative RA (RA-) and autoantibody-positive RA (RA+)] at diagnosis, after 2 years and over time. METHODS: All UA (n = 130), RA- (n = 176) and RA+ (n = 331) patients from the tREACH trial, a stratified single-blinded trial with a treat-to-target approach, were used. PRO comparisons between phenotypes at baseline and after 2 years were performed with analysis of variance, while a linear mixed model compared them over time. Effect sizes were weighted against the minimal clinically important differences (MCIDs) for each PRO. RESULTS: RA- patients had a higher disease burden compared with RA+ and UA. At baseline and after 2 years, RA- patients had more functional impairment and a poorer Physical Component Summary (PCS) compared with the other phenotypes, while they only scored worse for general health and morning stiffness duration at baseline. The MCIDs were exceeded at baseline, except for functional ability between RA+ and UA, while after 2 years only the MCID of the PCS was exceeded by RA- compared with UA and RA. After 2 years the PROs of all phenotypes improved, but PROs measuring functioning were still worse compared with the general population, even when patients had low disease activity. CONCLUSION: RA- patients had the highest disease burden of all phenotypes. Although most patients have low disease activity after treatment, all clinical phenotypes still have a similar significant impact on patients' lives, which is mainly physical. Therefore it is important to assess and address PROs in daily practice because of persistent disease burden despite low disease activity. TRIAL REGISTRATION: ISRCTN26791028.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Luurssen-Masurel N, Weel AEAM, Hazes JMW, et al. The impact of different (rheumatoid) arthritis phenotypes on patients' lives. Rheumatology (Oxford). 2021. PMID: 33237330. doi:10.1093/rheumatology/keaa845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。